Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oral Cavity Cancer”

2,682 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,682 results

Not applicableStudy completedNCT06231537
What this trial is testing

Visual Oral Examination for Early Detection of Oral Cancer in High-Risk Individuals

Who this might be right for
Mouth Neoplasms
Universidade Federal do Rio de Janeiro 1,152
Not applicableStudy completedNCT06730139
What this trial is testing

Oral Health Related Quality of Life in Head and Neck Cancer Survivors Within the First Year Following Treatment

Who this might be right for
Head and Neck Cancer
Ain Shams University 120
Large-scale testing (Phase 3)Study completedNCT00964977
What this trial is testing

Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.

Who this might be right for
Oropharyngeal CancerOral CancerLymph Node Metastasis
Johannes Gutenberg University Mainz 209
Testing effectiveness (Phase 2)Study completedNCT00003565
What this trial is testing

Docetaxel in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerHead and Neck Cancer+2 more
Alliance for Clinical Trials in Oncology 109
Early research (Phase 1)Study completedNCT00003430
What this trial is testing

L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Head and Neck CancerUnspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center 40
Testing effectiveness (Phase 2)UnknownNCT04813107
What this trial is testing

Evaluate the Safety and Efficacy of Oral APL-1202 in Combination With Tislelizumab Compared to Tislelizumab Alone as Neoadjuvant Therapy in Patients With Muscle Invasive Bladder Cancer

Who this might be right for
Muscle Invasive Bladder Cancer
Jiangsu Yahong Meditech Co., Ltd aka Asieris 79
Not applicableLooking for participantsNCT05554133
What this trial is testing

Precision Optical Guidance for Oral Biopsy

Who this might be right for
Oral Lesions
M.D. Anderson Cancer Center 90
Testing effectiveness (Phase 2)Study completedNCT01941992
What this trial is testing

Role of SAMITAL® in the Relief of Chemo-radiation (CT-RT) Induced Oral Mucositis in Head and Neck Cancer Patients

Who this might be right for
Head-and-neck Squamous Cell CarcinomaOral Mucositis
Istituto Oncologico Veneto IRCCS 120
Early research (Phase 1)Study completedNCT01061411
What this trial is testing

Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Clear Cell Sarcoma of the KidneyRecurrent Renal Cell CarcinomaStage III Renal Cell Cancer+1 more
Roswell Park Cancer Institute 16
Testing effectiveness (Phase 2)Study completedNCT00052611
What this trial is testing

Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 23
Early research (Phase 1)Study completedNCT00875264
What this trial is testing

Open-Label Study to Determine the Maximum Tolerated Oral Dose of the Kinase Inhibitor CEP-11981 in Patients With Advanced Cancer

Who this might be right for
Cancer
Cephalon 43
Large-scale testing (Phase 3)Study completedNCT00006799
What this trial is testing

Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer

Who this might be right for
AnorexiaCachexiaHead and Neck Cancer+1 more
Wake Forest University Health Sciences 13
Not applicableLooking for participantsNCT04484064
What this trial is testing

Optimization of the Targeted Anticancer Therapies

Who this might be right for
Cancer
Centre Hospitalier Universitaire Vaudois 500
Not applicableStudy completedNCT06325514
What this trial is testing

Artificial Intelligence Based Program to Classify Oral Cavity Findings Based on Clinical Image Analysis

Who this might be right for
Oral CancerOral Lichen PlanusFordyce Granule+4 more
Cairo University 241
Not applicableLooking for participantsNCT06148077
What this trial is testing

Manual Therapy on Oral Opening, Swallow Function and Upper Quarter Mobility on Head and Neck Cancer Survivors

Who this might be right for
Head and Neck CancerTrismusDysfunction
Universidad de La Frontera 70
Testing effectiveness (Phase 2)Looking for participantsNCT07079475
What this trial is testing

Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN8)

Who this might be right for
Non-Small Cell Lung Cancer
Dizal (Jiangsu) Pharmaceutical Co., Ltd. 200
Not applicableStudy completedNCT03285893
What this trial is testing

Oral Cell DNA Adducts in Smokers

Who this might be right for
Lung Cancer
University of Minnesota 281
Early research (Phase 1)Active Not RecruitingNCT05076552
What this trial is testing

Assess the Safety, Pharmacokinetics, and Antitumor Activity of Oral TACH101 in Participants With Advanced or Metastatic Cancer

Who this might be right for
Advanced CancerMetastatic Solid TumorSolid Tumor
Tachyon Therapeutics, Inc. 30
Not applicableUnknownNCT00173381
What this trial is testing

The Role of Lymphangiogenesis in Head and Neck Cancer Metastasis

Who this might be right for
Oral CancerLaryngeal CancerHypopharyngeal Cancer
National Taiwan University Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00074867
What this trial is testing

Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer

Who this might be right for
Ovarian NeoplasmsPeritoneal NeoplasmsFallopian Tube Neoplasms
Pfizer 29
Load More Results